Pirfenidone: A novel hypothetical treatment for COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet · 2020 · 29.1K citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +12

Glutamate neurotoxicity and diseases of the nervous system

Dennis W. Choi · Neuron · 1988 · 8K citations

Life Sciences, Neurobiology, Neuroscience +14

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Chi Zhang, Zhao Wu, Jiawen Li et al. · International Journal of Antimicrobial Agents · 2020 · 1.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14